- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
[作者：Rustin, GJS; van der Burg, MEL; Griffin, CL; Guthrie, D; Lamont, A; Jayson, GC; Kristensen, G; Mediola, C; Coens, C; Qian, WD; Parmar, MKB; Swart, AM,期刊：Lancet, 页码：1155-1163 , 文章类型： Article，,卷期：2010年376-9747]
- Background Serum CA125 concentration often rises several months before clinical or symptomatic relapse in women with ovarian cancer. In the MRC OV05/EORTC 55955 collaborative trial, we aimed to establish the benefits of ...
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
[作者：Hallek, M; Fischer, K; Fingerle-Rowson, G; Fink, AM; Busch, R; Mayer, J; Hensel, M; Hopfinger, G; Hess, G; von Grunhagen, U; Bergmann, M; Catalano, J; Zinzani, PL; Caligaris-Cappio, F; Seymour, JF; Berrebi, A; Jager, U; Cazin, B; Trneny, M; Westermann, A; Wendtner, CM; Eichhorst, BF; Staib, P; Buhler, A; Winkler, D; Zenz, T; Bottcher, S; Ritgen, M; Mendila, M; Kneba, M; Dohner, H; Stilgenbauer, S,期刊：Lancet, 页码：1164-1174 , 文章类型： Article，,卷期：2010年376-9747]
- Background On the basis of promising results that were reported in several phase 2 trials, we investigated whether the addition of the monoclonal antibody rituximab to first-line chemotherapy with fludarabine and cycloph...
- Lymphatic filariasis and onchocerciasis
[作者：Taylor, MJ; Hoerauf, A; Bockarie, M,期刊：Lancet, 页码：1175-1185 , 文章类型： Article，,卷期：2010年376-9747]
- Lymphatic filariasis and onchocerciasis are parasitic helminth diseases that constitute a serious public health issue in tropical regions. The filarial nematodes that cause these diseases are transmitted by blood-feeding...
|